Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2026-01-23 @ 4:19 PM
Study NCT ID:
NCT00185159
Status:
COMPLETED
Last Update Posted:
2010-01-20
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olmesartan Medoxomil in Diabetes Mellitus
Sponsor:
Sankyo Pharma Gmbh
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SE-866/44
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Heiko Rauer
Old Organization:
Daiichi Sankyo Europe, GmbH